Guardant Health Files 8-K on Financials
Ticker: GH · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Guardant Health dropped an 8-K on Jan 13th covering financials. Check it out.
AI Summary
Guardant Health, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company is headquartered at 3100 Hanover Street, Palo Alto, California.
Why It Matters
This filing provides investors with updated information on Guardant Health's financial performance and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Guardant Health, Inc. (company) — Registrant
- January 13, 2025 (date) — Date of earliest event reported
- 3100 Hanover Street, Palo Alto, California 94304 (address) — Principal executive offices
- 855-698-8887 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not detail specific figures within the provided text.
What is the purpose of filing an 8-K for 'Results of Operations and Financial Condition'?
Companies file an 8-K to report significant events, including material changes in their financial condition or operations, to keep investors informed.
When was this 8-K filing submitted?
The filing was submitted on January 13, 2025.
What other items are included in this 8-K filing besides financial condition?
This filing also includes 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
Where is Guardant Health, Inc. headquartered?
Guardant Health, Inc. is headquartered at 3100 Hanover Street, Palo Alto, California.
Filing Stats: 553 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-01-13 16:17:17
Key Financial Figures
- $0.00001 — nge on which registered Common Stock, $0.00001 par value per share GH The Nasdaq G
Filing Documents
- d890861d8k.htm (8-K) — 25KB
- d890861dex991.htm (EX-99.1) — 21KB
- g890861g90r43.jpg (GRAPHIC) — 6KB
- 0001193125-25-005319.txt ( ) — 176KB
- gh-20250113.xsd (EX-101.SCH) — 3KB
- gh-20250113_lab.xml (EX-101.LAB) — 17KB
- gh-20250113_pre.xml (EX-101.PRE) — 11KB
- d890861d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release of Guardant Health, Inc., dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: January 13, 2025 By: /s/ Michael Bell Michael Bell Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer)